References
- Arora S, Ali J, Ahuja A, et al. (2005). Floating drug delivery systems: a review. AAPS PharmSciTech 6:E372–90
- Atyabi F, Sharma H, Mohammad H, Fell J. (1996). In vitro evaluation of a novel gastro retentive formulation based on ion exchange resins. J Control Release 42:105–13
- Bhupesh D, Raghuram C. (2010). An open-label randomized cross-over bioequivalence study of lafutidine 10 mg under fasting condition. World J Gastrointest Pharmacol Ther 1:112–18
- Caldwell L, Gardner R, Cargill R, et al. (1988). Drug delivery device which can be retained in the stomach for a controlled period of times. US patents, 30th August 1988; 4,767,627
- Chavanpatil MD, Jain P, Chaudhari S, et al. (2006). Novel sustained release, swellable bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 316:89–92
- Chien Y. (1992). Novel drug delivery systems. 2nd ed. New York: Marcel Dekker Inc., 171–6
- Desai S, Bolton S. (1993). A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm Res 10:1321–5
- Dollery C. (1999). Therapeutic drugs. Edinburgh, Scotl: Churchil Livingstone, C113YC117
- Dorozynski P, Jachowicz R, Kulinowski P, et al. (2004). The macromolecular polymers for the preparation of hydrodynamically balanced systems – methods of evaluation. Drug Dev Ind Pharm 30:947–57
- Gandhi RB, Robinson JR. (1998). Bioadhesion in drug delivery. Ind J Pharm Sci 50:145–52
- Gershon S, Pader M, Balsam M, et al. (1972). Cosmetics science and technology. New York: Wiley-Interstice, 423
- Gibaldi M, Feldman S. (1967). Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci 56:1238–42
- Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9
- Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface agitation. Ind Eng Chem 23:923–93
- Ikawa K, Shimatani T, Hayato S, et al. (2007). Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine. Biol Pharm Bull 30:1003–6
- International Conference on Harmonization Steering Committee (1999). Q1A – Stability testing of new drug substances and products
- Korsmeyer R, Gurny R, Peppas N. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
- Lachman L, Hebert AL, Joseph LK. (1987). Theory and practice of pharmacy. 3rd ed. Varghese Publication House, 430–4
- Mathews BR. (1999). Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 25:831–56
- Nokano M, Ogata A. (1984). Examination of natural gums as matrices for sustained release of Theophylline. Chem Pharm Bul 32:782–5
- Onodera S, Shibata M, Tanaka M, et al. (1995). Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. Jpn J Pharmacol 68:161–73
- Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–11
- Rosa M, Zia H, Rhodes T. (1994). Dosing testing in vitro bioadhesive floating drug delivery system for oral application. Int J Pharm 105:65–70
- Singh BN, Kim KH. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 63:235–59
- Suvarna K, Manisha S, Sugandha V. (2012). Development and validation of an UV spectrophotometric method for estimation of Lafutidine in bulk and tablet. In: contemporary investigation and observation in pharmacy, 1:5–8
- Whitehead L, Fell JT, Collett JH, et al. (1998). Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release 55:3–12